NBIO Nascent Biotech Inc

235
Loading...
Loading...
Nascent Biotech, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of monoclonal antibodies for the treatment of various forms of cancer. It focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Its products include Pritumumab, CLNH5, and MultiPharm. The company was founded by Mark C. Glassy on March 3, 2014 and is headquartered in North Palm Beach, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Nascent Biotech Inc?
What is the 52-week high for Nascent Biotech Inc?
What is the 52-week low for Nascent Biotech Inc?
What is Nascent Biotech Inc stock price today?
What was Nascent Biotech Inc stock price yesterday?
What is the PE ratio of Nascent Biotech Inc?
What is the Price-to-Book ratio of Nascent Biotech Inc?
What is the 50-day moving average of Nascent Biotech Inc?

Latest NBIO News

View
No NBIO news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.